Lopez R, Ben El Khyat C, Chen Y, Tsering T, Dickinson K, Bustamante P
Sci Rep. 2025; 15(1):8430.
PMID: 40069225
PMC: 11897354.
DOI: 10.1038/s41598-025-91873-5.
Wang M, Wang Z, Liu T, Zhao Y, Sun X, Lu B
Mater Today Bio. 2025; 31:101527.
PMID: 39968525
PMC: 11834113.
DOI: 10.1016/j.mtbio.2025.101527.
Cybulski P, Bravo M, Chen J, Van Zundert I, Krzyzowska S, Taemaitree F
Front Cell Dev Biol. 2025; 12:1520078.
PMID: 39925825
PMC: 11802510.
DOI: 10.3389/fcell.2024.1520078.
Naskar A, Kilari S, Baranwal G, Kane J, Misra S
Bioengineering (Basel). 2025; 11(12.
PMID: 39768040
PMC: 11673055.
DOI: 10.3390/bioengineering11121222.
Cen B, Zhang J, Pan X, Xu Z, Li R, Chen C
Int J Nanomedicine. 2024; 19:11517-11537.
PMID: 39539970
PMC: 11559232.
DOI: 10.2147/IJN.S483252.
Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux.
Chen S, Zhang W, Tang C, Rong X, Liu Y, Luo Y
J Nanobiotechnology. 2024; 22(1):664.
PMID: 39465387
PMC: 11514794.
DOI: 10.1186/s12951-024-02939-x.
Comparative Assessment of Cellular Responses to Microscale Silica Morphologies in Human Gastrointestinal Cells: Insights for Occupational Health.
Yamin M, Liu J, Sayes C
Int J Environ Res Public Health. 2024; 21(10).
PMID: 39457349
PMC: 11508045.
DOI: 10.3390/ijerph21101376.
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer.
Hoshi R, Gorospe K, Labouta H, Azad T, Lee W, Thu K
Pharmaceutics. 2024; 16(9).
PMID: 39339217
PMC: 11434872.
DOI: 10.3390/pharmaceutics16091181.
Green-Synthesized Characterization, Antioxidant and Antibacterial Applications of CtAC/MNPs-Ag Nanocomposites.
Baran A, Ertas E, Firat Baran M, Eftekhari A, Gunes Z, Keskin C
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931439
PMC: 11206647.
DOI: 10.3390/ph17060772.
Porous Semiconducting Polymer Nanoparticles as Intracellular Biophotonic Mediators to Modulate the Reactive Oxygen Species Balance.
Criado-Gonzalez M, Marzuoli C, Bondi L, Gutierrez-Fernandez E, Tullii G, Lagonegro P
Nano Lett. 2024; .
PMID: 38842262
PMC: 11194851.
DOI: 10.1021/acs.nanolett.4c01195.
Iron Oxide Nanoparticles: Selectively Targeting Melanoma Cells In Vitro by Inducing DNA Damage via H2AX Phosphorylation and Hindering Proliferation through ERK Dephosphorylation.
Prokopiou D, Chilla A, Margheri F, Fibbi G, Laurenzana A, Efthimiadou E
Pharmaceutics. 2024; 16(4).
PMID: 38675188
PMC: 11054682.
DOI: 10.3390/pharmaceutics16040527.
Empowering Naringin's Anti-Inflammatory Effects through Nanoencapsulation.
Marinho A, Seabra C, Lima S, Lobo-da-Cunha A, Reis S, Nunes C
Int J Mol Sci. 2024; 25(8).
PMID: 38673736
PMC: 11050564.
DOI: 10.3390/ijms25084152.
Enhancing Cisplatin Efficacy with Low Toxicity in Solid Breast Cancer Cells Using pH-Charge-Reversal Sericin-Based Nanocarriers: Development, Characterization, and Biological Assessment.
Bahremand K, Aghaz F, Bahrami K
ACS Omega. 2024; 9(12):14017-14032.
PMID: 38560009
PMC: 10976391.
DOI: 10.1021/acsomega.3c09361.
Gallic Acid-Modified Polyethylenimine-Polypropylene Carbonate-Polyethylenimine Nanoparticles: Synthesis, Characterization, and Anti-Periodontitis Evaluation.
Xie Z, Gao B, Liu J, He J, Liu Y, Gao F
ACS Omega. 2024; 9(12):14475-14488.
PMID: 38559964
PMC: 10976379.
DOI: 10.1021/acsomega.4c00261.
Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer.
Salvanou E, Kolokithas-Ntoukas A, Prokopiou D, Theodosiou M, Efthimiadou E, Kozminski P
Molecules. 2024; 29(5).
PMID: 38474542
PMC: 10934748.
DOI: 10.3390/molecules29051030.
The Potential of PIP3 in Enhancing Wound Healing.
Blitsman Y, Hollander E, Benafsha C, Yegodayev K, Hadad U, Goldbart R
Int J Mol Sci. 2024; 25(3).
PMID: 38339058
PMC: 10855400.
DOI: 10.3390/ijms25031780.
Nominally identical microplastic models differ greatly in their particle-cell interactions.
Wieland S, Ramsperger A, Gross W, Lehmann M, Witzmann T, Caspari A
Nat Commun. 2024; 15(1):922.
PMID: 38297000
PMC: 10830523.
DOI: 10.1038/s41467-024-45281-4.
Exploring the Impact of Nanoparticle Stealth Coatings in Cancer Models: From PEGylation to Cell Membrane-Coating Nanotechnology.
Gravan P, Pena-Martin J, Andres J, Pedrosa M, Villegas-Montoya M, Galisteo-Gonzalez F
ACS Appl Mater Interfaces. 2023; 16(2):2058-2074.
PMID: 38159050
PMC: 10797597.
DOI: 10.1021/acsami.3c13948.
Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity.
Ngo H, Bak H, Nguyen H, Lee K, Park C, Lee B
Int J Nanomedicine. 2023; 18:2325-2344.
PMID: 37168738
PMC: 10166105.
DOI: 10.2147/IJN.S401048.
Nanoparticle (NP) Loading by Direct Incubation with Extracellular Vesicles-Secretor Cells: NP Encapsulation and Exosome Characterization.
Martin-Pardillos A, Martin-Duque P
Methods Mol Biol. 2023; 2668:121-132.
PMID: 37140794
DOI: 10.1007/978-1-0716-3203-1_10.